Work

A mix of views: Perspectives on pregnant women's participation in maternal vaccine trials

Year: 2025

Type: article

Abstract: BACKGROUND: The aim of this study was to investigate perspectives on participation in a Group B Streptococcus (GBS) maternal vaccine trial among pregnant women, their partners, family members, friends and other stakeholders in Kampala, Uganda. METHODS: We conducted focus group discussions, in-depth interviews and key informant interviews from October 2022 to February 2023 with 56 participants: 36 pregnant or breastfeeding women, 5 women not in the trial, 5 partners of women in trial, 5 healthcare workers, and 5 community stakeholders. This cross-sectional study was embedded within a GBS maternal vaccine trial conducted at the national referral hospital. All study participants were recruited after seeking hospital administrative approval and individual consent. Women taking part in the GBS trial were contacted by phone and invited to the hospital for detailed information during their follow-up visits. Eligible pregnant women were aged 18-39, and participating in a GBS maternal vaccine trial. Their identifiers were shared with the social science team after approval. With the support of the health visitors, the women were contacted. Non-trial participants with similar characteristics were recruited through antenatal clinic staff. Both groups were purposively sampled across age brackets (18-24 years, 25-32 years, 33-39 years) for discussion groups. Women's partners were recruited through contact information provided by the women, and community stakeholders were mobilized with assistance from a Community Advisory Board member. Healthcare workers involved in the trial, including doctors, nurses, and midwives, as well as a research ethics committee member, were directly approached and invited to participate. All participants provided informed consent. RESULTS: The participants expressed various concerns about participation of pregnant women in maternal vaccine trials. While family members, partners, friends, and community members, expressed concern for the safety of pregnant women and their unborn babies, the specific nature of these concerns and the focus on vaccine intentions differed. Pregnant women primarily focused on the safety of their babies, while partners and family members worried about both maternal and fetal safety. Friends were more concerned about the vaccine itself, community members were suspicious of vaccines in general, fear of possible harm and questioned the intent for vaccine development. CONCLUSIONS: Building trust, providing accurate information, and engaging in transparent communication about the safety and intentions of maternal vaccines are crucial steps in fostering understanding and increasing participation in vaccine trials. Efforts to dispel myths, correct misconceptions, and address the underlying fears that contribute to hesitancy within these diverse stakeholder groups need to be discussed with targeted study populations.

Source: Vaccine

DOI: 10.1016/j.vaccine.2025.127627

Authors: Phiona Nalubega, Ritah Namugumya, Mary Kyohere, Janet Seeley, Kirsty Le Doare, Agnes Ssali